Vitalhub (TSE:VHI) Given a C$14.00 Price Target by Scotiabank Analysts

Vitalhub (TSE:VHI) received a C$14.00 price objective from Scotiabank in a report released on Thursday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Scotiabank’s price objective suggests a potential upside of 19.25% from the company’s current price.

Other equities analysts also recently issued reports about the stock. Cormark upped their price target on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a report on Wednesday, October 2nd. Canaccord Genuity Group increased their price target on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a report on Thursday, January 16th. Finally, TD Securities raised Vitalhub to a “strong-buy” rating in a research report on Monday, November 25th. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of C$10.71.

Vitalhub Stock Performance

Shares of TSE:VHI traded up C$0.26 on Thursday, reaching C$11.74. The company’s stock had a trading volume of 60,649 shares, compared to its average volume of 125,785. The company has a 50-day simple moving average of C$11.26 and a 200 day simple moving average of C$9.63. The company has a market cap of C$596.98 million, a P/E ratio of 106.73, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 52-week low of C$4.36 and a 52-week high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.